Status:
COMPLETED
Salutogenic Approach Based Interview With People With Schizophrenia
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Salutogenesis
Mental Health Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study determines the effectiveness of the interviewing based on salutogenic approach on the sense of coherence and resilience of people with schizophrenia. For this, while the intervention group ...
Detailed Description
Schizophrenia is a chronic and serious disease that affecting 20 million people in the world. Because of the problems these individuals face in cognitive, emotional, and behavioral domains, they have ...
Eligibility Criteria
Inclusion
- Inclusion criteria of the study:
- Getting diagnosed with schizophrenia or schizoaffective disorder
- Completing acute treatment and being at maintenance medication period
- Exclusion criteria of the study
- Being at the period of psychotic relapse
- Having mental development disorder
- Being under the influence of alcohol-drugs
- Having diagnosed with personal disorder
- Being considered unsuitable to include in the group study by doctors and nurses of CMHC.
Exclusion
Key Trial Info
Start Date :
December 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04740944
Start Date
December 31 2018
End Date
December 31 2019
Last Update
February 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University - Cerrahpasa Institute of Granduate Studies
Istanbul, Turkey (Türkiye)